Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess existing measures of pathologic response to neoadjuvant therapy in esophageal and junctional cancer, and to recommend an optimum classification.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann. Surg.

Title: Annals of surgery

ISSN (Electronic): 1528-1140

ISSN (Print): 0003-4932

Publication date (Electronic): Nov 2013

Volume: 258

Issue: 5

Affiliations

[1 ] *Department of Surgery, Trinity Centre for Health Sciences, Trinity College Dublin, and St James Hospital †Department of Biostatistics, University College Dublin ‡Department of Pathology, St James Hospital, Dublin, Ireland.

Article

DOI: 10.1097/SLA.0b013e3182a66588

PubMed ID: 24045450

SO-VID: 7b4397d5-28cd-4f56-8ddb-a00ff78380c0

History

Data availability:

Comments

Comment on this article

scite_

Cited by 30

See all cited by